News

Pharmabiz3h
BD introduces landmark cell analyzer featuring breakthrough spectral and real-time cell imaging technologies
BD introduces landmark cell analyzer featuring breakthrough spectral and real-time cell imaging technologies: Franklin Lakes, ...
Pharmabiz5h
Gujarat FDCA unveils strategic expansion with new drug testing lab in Ahmedabad: Dr H G Koshia
Shardul Nautiyal, Mumbai Wednesday, May 14, 2025, 08:00 Hrs [IST] ...
Pharmabiz5h
BDCDA cautions on unauthorized channels and infiltration of counterfeit medicines into Karnataka
BDCDA cautions on unauthorized channels and infiltration of counterfeit medicines into Karnataka: Nandita Vijayasimha, ...
Pharmabiz43m
AstraZeneca to showcase latest research on comprehensive portfolio and pipeline aimed at transforming respiratory diseases at ATS 2025
AstraZeneca to showcase latest research on comprehensive portfolio and pipeline aimed at transforming respiratory diseases at ATS 2025: Cambridge, UK Wednesday, May 14, 2025, 13:0 ...
Pharmabiz1h
Barentz to strengthen its pharmaceuticals market presence in Asia Pacific through the envisaged acquisition of Fengli in China
Barentz to strengthen its pharmaceuticals market presence in Asia Pacific through the envisaged acquisition of Fengli in China: Singapore Wednesday, May 14, 2025, 12:00 Hrs [IST] ...
Pharmabiz1h
Geri Care Hospital in Chennai receives accreditation from National Board of Examinations in Medical Sciences
Geri Care Hospital in Chennai receives accreditation from National Board of Examinations in Medical Sciences: Our Bureau, Chennai Wednesday, May 14, 2025, 12:40 Hrs [IST] In a lan ...
Pharmabiz1h
India solidifies position as most attractive global CDMO destination: LoEstro Report
India solidifies position as most attractive global CDMO destination: LoEstro Report: Our Bureau, Bengaluru Wednesday, May 14, 2025, 12:20 Hrs [IST] India is poised to lead the gl ...
Pharmabiz2h
UK MHRA grants marketing approval for Takeda’s Adzynma to treat congenital thrombotic thrombocytopenic purpura
UK MHRA grants marketing approval for Takeda’s Adzynma to treat congenital thrombotic thrombocytopenic purpura: United Kingdom Wednesday, May 14, 2025, 11:00 Hrs [IST] The Medic ...
Pharmabiz4h
Ten-year APHINITY data show Roche’s Perjeta-based regimen reduced the risk of death by 17% in people with HER2-positive early-stage breast cancer
91.6% of people treated with the Perjeta-based regimen were alive at ten years versus 89.8% of those treated with Herceptin, chemotherapy, and placebo (hazard ratio [HR]=0.83, 95% CI: 0.69-1.00, ...
Pharmabiz5h
Telangana DCA issues advisory to public & stakeholders to check QR code to block entry of counterfeits
Peethaambaran Kunnathoor, Chennai Wednesday, May 14, 2025, 08:00 Hrs [IST] ...
Pharmabiz5h
DTAB asks DCGI to take up withdrawal of license for certain FDC antibiotics with SLAs
DTAB asks DCGI to take up withdrawal of license for certain FDC antibiotics with SLAs: Gireesh Babu, New Delhi Wednesday, May 14, 2025, 08:00 Hrs [IST] The Drugs Technical Advisor ...
Pharmabiz5h
Lifesciences sector maximises adoption of advanced technologies to unlock new possibilities
Lifesciences sector maximises adoption of advanced technologies to unlock new possibilities: Nandita Vijayasimha, Bengaluru Wednesday, May 14, 2025, 08:00 Hrs [IST] Life sciences ...